HR
HealthCare Royalty Partners
Private EquityActiveHealthCare Royalty Partners is a global investment firm that partners with healthcare companies, non-profit institutions and inventors.
14
Investments
8
Exits
$7.0B
AUM
57.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for HealthCare Royalty Partners.
Investment Thesis & Strategy
HealthCare Royalty Partners invests in various stages of healthcare companies, including biotech, fintech, and asset management, seeking to partner with innovative healthcare companies and institutions.
Notable Exits
CompanyTypeYearValue / Acquirer
Biohaven PharmaceuticalAcquisition2022$11.6B
Portola PharmaceuticalsAcquisition2020$1.2B
Acadia HealthcareIPO2014—
United TherapeuticsAcquisition2014—
Esperion TherapeuticsIPO2013—
Intercept PharmaceuticalsIPO2012—
Pacira BioSciencesIPO2011—
Jazz PharmaceuticalsIPO2004—
Frequently Asked Questions
HealthCare Royalty Partners focuses on Series B, Series C+ stage investments.
Related Investors
Tullis Health Investors
Stamford, United States · 39 deals
Stonehenge Capital
Stamford, United States · 32 deals
Cornerstone Equity Investors
Stamford, United States · 11 deals
Shelter Growth Capital Partners
Stamford, United States · 7 deals
Atlantic Street Capital
Stamford, United States · 6 deals
Lumis Partners
Stamford, United States · 6 deals